Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX) [Yahoo! Finance]
HilleVax, Inc. (HLVX)
Company Research
Source: Yahoo! Finance
The transaction was executed at a price of $14.95 per share, resulting in a total sale value of $269,100. Warning! GuruFocus has detected 2 Warning Sign with HLVX. HilleVax Inc is a biopharmaceutical company focused on the development and commercialization of novel vaccines. The company's lead product candidate is in development to prevent norovirus gastroenteritis. HilleVax applies innovative technologies to create vaccines that address significant unmet medical needs. Over the past year, the insider has sold a total of 32,866 shares of HilleVax Inc and has not made any purchases of the stock. The recent sale by the insider is part of a series of transactions over the same period. The insider transaction history for HilleVax Inc indicates a trend of 10 insider sells and no insider buys over the past year. This could suggest that insiders have been more inclined to sell shares than to acquire them. On the date of the insider's most recent transaction, shares of HilleVax Inc
Show less
Read more
Impact Snapshot
Event Time:
HLVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HLVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HLVX alerts
High impacting HilleVax, Inc. news events
Weekly update
A roundup of the hottest topics
HLVX
News
- HilleVax: Mid-2024 Data Is Crucial Inflection Point For Continued Valuation [Seeking Alpha]Seeking Alpha
- HilleVax, Inc. (NASDAQ: HLVX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.MarketBeat
- HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress [Yahoo! Finance]Yahoo! Finance
- HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company ProgressGlobeNewswire
- Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX) [Yahoo! Finance]Yahoo! Finance
HLVX
Earnings
- 3/20/24 - Beat
HLVX
Analyst Actions
- 3/21/24 - HC Wainwright
HLVX
Sec Filings
- 5/3/24 - Form 4
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- HLVX's page on the SEC website